当前位置:首页 - 行情中心 - 昭衍新药(603127) - 财务分析

昭衍新药

(603127)

  

流通市值:106.61亿  总市值:126.81亿
流通股本:6.30亿   总股本:7.50亿

昭衍新药(603127)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2023年年度实现净利润3.92亿元,每股收益0.53元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2023年年度最新股东权益828104.04万元,未分配利润216397.15万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2023年年度最新总资产1002715.96万元,负债174611.92万元。

利润表
报告期2023-12-312023-09-302023-06-302023-03-31
营业总收入2,376,486,797.11,587,079,779.381,012,077,288.18369,386,010.95
营业总成本1,622,010,226.391,104,837,171.01714,196,615.6262,811,341.25
营业利润507,096,321.21392,084,940116,839,105.61214,369,686.98
利润总额506,950,437.23391,985,180.41116,935,671.75214,328,923.94
净利润391,552,561.64326,197,002.6589,508,170.24187,710,078.62
其他综合收益4,960,762.6710,184,198.0213,252,126.55-4,402,644.75
综合收益总额396,513,324.31336,381,200.67102,760,296.79183,307,433.87
资产负债表
报告期2023-12-312023-09-302023-06-302023-03-31
流动资产合计7,121,967,340.117,248,202,099.955,781,980,364.116,069,406,073.03
非流动资产合计2,905,192,290.362,984,467,964.584,437,329,670.944,478,677,682.25
资产总计10,027,159,630.4710,232,670,064.5310,219,310,035.0510,548,083,755.28
流动负债合计1,467,365,088.641,690,352,621.161,900,397,225.761,854,544,562.53
非流动负债合计278,754,126.75302,170,027.52294,852,420.91331,392,775.99
负债合计1,746,119,215.391,992,522,648.682,195,249,646.672,185,937,338.52
归属于母公司股东权益合计8,279,315,724.358,234,384,077.378,018,014,677.358,355,031,298.11
股东权益合计8,281,040,415.088,240,147,415.858,024,060,388.388,362,146,416.76
负债和股东权益合计10,027,159,630.4710,232,670,064.5310,219,310,035.0510,548,083,755.28
现金流量表
报告期2023-12-312023-09-302023-06-302023-03-31
经营活动现金流入小计2,433,306,501.421,874,131,001.011,261,717,481.39635,825,537.05
经营活动现金流出小计1,810,431,362.981,425,690,782.591,015,507,733.02649,493,721.11
经营活动产生的现金流量净额622,875,138.44448,440,218.42246,209,748.37-13,668,184.06
投资活动现金流入小计623,903,128.48528,639,464.14326,802,768.55222,354,944.59
投资活动现金流出小计939,332,589.88665,787,220.01369,109,478.54115,878,731.98
投资活动产生的现金流量净额-315,429,461.4-137,147,755.87-42,306,709.99106,476,212.61
筹资活动现金流入小计----
筹资活动现金流出小计361,677,897.08333,289,197.7593,602,620.4724,852,351.87
筹资活动产生的现金流量净额-361,677,897.08-333,289,197.75-93,602,620.47-24,852,351.87
汇率变动对现金及现金等价物的影响8,409,667.4813,801,951.617,779,109.73-6,273,367.27
现金及现金等价物净增加额-45,822,552.56-8,194,783.6128,079,527.6461,682,309.41
期末现金及现金等价物余额2,853,647,027.972,891,274,796.933,027,549,108.172,961,151,889.94
最新报告期:2024-04-15
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
国信证券张佳博,彭思宇0.540.730.802024-04-15
中泰证券崔少煜,祝嘉琦0.540.670.842024-04-07
浙商证券孙建,王帅0.370.450.712024-04-02
太平洋周豫0.600.670.782024-04-02
中国银河程培0.660.770.902024-04-01
TOP↑